3Lieberman JA. Understanding the mechanism of atypical antipsy-chotic drugs[J]. Br J Psychiatry, 1993, 163:17.
二级参考文献9
1[1]Tamminga CA,Buchanan RW,Gold JM.The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.Int Clin Psychopharmacol,1998:s21
2[2]Morice R,Delahunty A.Frontal/executive impairment in schizophrenia.Schizophrenia Bull,1996,22:125
3[3]Gallhofer B,Bauer U,Lis S,et al.Cognitive dysfunction in schizophrenia:comparison of treatment with atypical antipsychotic agents and conventional neuroleptics.Euro Neuropsychopharmacology,1996,6:13
4[4]Nathaniel-James DA,Browa R,Ron MA.Memory impairment in schizophrenia:its' relationship to executive function.Schizophr Res,1996,21:85
5[5]Mar FL,Lee PWH.Cognitive deficit measures in schizophrenia:factor structure and clinical correlates.Am J Psychiatry,1997,154:39
6[6]Buchanan RW,Strauss ME,Breier A,et al.Attentional impairments in deficit and nondeficit forms of schizophrenia.Am J Psychiatry,1997,154:363
7[7]Green MF.What are the functional consequences of neurocognitive defieits on schizophrenia?Am J Psychiatry,1996,153:321
8[8]Gold JM,Harvey PD.Cognitive deficits in schizophrenia.Schizophrenia,1993,16:295
9[9]Rubin P,Holm A,Moller-Madsen S,et al.Neuropsychological deficit in newly diagnosed patients with schizophrenia or schizophreniform disorder.Acta Psychiatr Scand,1995,92:35
